1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,350 | 3,430 | 22:41 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.06. | Riber partners with Denmark's NQCP, initiating phase II of ROSIE | 1 | Semiconductor Today | ||
| 18.06. | RIBER reaffirms its strategic roadmap at the Annual General Meeting held on June 18, 2025 | 512 | GlobeNewswire (Europe) | RIBER reaffirms its strategic roadmap at the Annual General Meeting held on June 18, 2025 Bezons, June 18, 2025 - 5:45 PM - RIBER, a global market leader for molecular beam epitaxy (MBE) equipment... ► Artikel lesen | |
| RIBER Aktie jetzt für 0€ handeln | |||||
| 17.06. | RIBER completes phase I of ROSIE with a partnership agreement signed with NQCP, a leading research center in Denmark | 593 | GlobeNewswire (Europe) | RIBER completes phase I of ROSIE with a partnership agreement signed with NQCP, a leading research center in Denmark Bezons (France), June 17, 2025 - 6:00pm (CET) - RIBER, the global leader in... ► Artikel lesen | |
| 03.06. | Riber receives order from Asia for MBE 412 research system | 4 | Semiconductor Today | ||
| 03.06. | RIBER receives an order in Asia for an MBE 412 research system | 1 | GlobeNewswire (USA) | ||
| 13.05. | Australian National Fabrication Facility orders Riber MBE 412 cluster platform | 2 | Semiconductor Today | ||
| 13.05. | RIBER secures a major order for an MBE 412 cluster system in Australia | 3 | GlobeNewswire (USA) | ||
| 10.04. | Riber's annual revenue grows 4.8% to €41.2m | 3 | Semiconductor Today | ||
| 09.04. | RIBER reports solid growth in sales and earnings in 2024 | 993 | GlobeNewswire (Europe) | RIBER reports solid growth in sales and earnings in 2024 Revenues: €41.2m (+5%)Income from ordinary operations: €4.5m, representing 11% of revenues Net income: €4.1m (+21%)Proposed payout of €0.08... ► Artikel lesen | |
| 03.02. | Riber's full-year revenue grows 5% to €41.2m in 2024 | 1 | Semiconductor Today | ||
| 29.01. | Riber: 2024 business growth in line with guidance | 1.256 | GlobeNewswire (Europe) | 2024 business growth in line with guidance Revenues up +5% to €41.2mOrder book at end-2024: €21.7m Bezons (France), January 29, 2025 - 8:00 am (CET) - RIBER, a global market leader for MBE equipment... ► Artikel lesen | |
| 09.01. | RIBER secures a repeat order for an MBE 412 cluster system in the USA | 3.471 | GlobeNewswire (Europe) | RIBER secures a repeat order for an MBE 412 cluster system in the USA Bezons (France), January 9, 2025 - 8:00am (CET) - RIBER, the global leader for Molecular Beam Epitaxy (MBE) equipment serving... ► Artikel lesen | |
| 30.10.24 | RIBER: Solid Business Growth at End-September 2024 | 873 | GlobeNewswire (Europe) | SOLID BUSINESS GROWTH AT END-SEPTEMBER 2024 Revenues up +14% to €18.5mOrder book strengthened to €38.3m (+14%) Bezons, October 30, 2024 - 8:00am - RIBER, the global leader for molecular beam epitaxy... ► Artikel lesen | |
| 30.09.24 | RIBER receives order to equip an autonomous pilot line for the design and manufacturing of optical devices in Europe | 702 | GlobeNewswire (Europe) | RIBER receives order to equip an autonomous pilot line for the design and manufacturing of optical devices in Europe Bezons (France), September 30, 2024 - 8:00 am (CET) - RIBER, the global leader... ► Artikel lesen | |
| 25.09.24 | RIBER: 2024 first-half earnings | 695 | GlobeNewswire (Europe) | 2024 first-half earnings Solid half-year revenues growth (+13%) Gross margin up by 21% and operating income at breakevenNet profit of €0.2m despite the lower seasonal revenues Strong increase in... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 29,700 | -1,00 % | EQS-News: Formycon AG: Formycon schließt Patientenrekrutierung für die klinische Entwicklung des Keytruda®-Biosimilar-Kandidaten FYB206 erfolgreich ab | EQS-News: Formycon AG
/ Schlagwort(e): Studie
Formycon schließt Patientenrekrutierung für die klinische Entwicklung des Keytruda®-Biosimilar-Kandidaten FYB206 erfolgreich ab
10.07.2025... ► Artikel lesen | |
| KOPIN | 1,874 | +12,08 % | Kopin Corp Trending Amid Recent ESG Framework Announcement, Stock Spikes 6.7% After Hours | ||
| ONTO INNOVATION | 85,00 | +0,59 % | Benchmark bestätigt Kaufempfehlung für Onto Innovation | ||
| SOLESENCE | 4,090 | +7,92 % | Solésence, Inc.: Solésence Announces Uplisting to Nasdaq | Trading set to begin Tuesday, April 8 under new ticker "SLSN" ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions... ► Artikel lesen | |
| DOTZ NANO | 0,022 | +7,32 % | XFRA 57N: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| NVE | 69,50 | +2,21 % | Dividendenbekanntmachungen (19.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AFFILIATED MANAGERS GROUP INC US0082521081 0,01 USD 0,0089 EUR AIR LIQUIDE SA FR0000120073 - 3,3 EUR ALA SPA IT0005446700 - 0,75... ► Artikel lesen | |
| GAUZY | 7,180 | +4,36 % | Gauzy Ltd. Sets Date for Second Quarter 2025 Results | ||
| FENDX TECHNOLOGIES | 0,044 | +2,83 % | Fendx Technologies Inc: Fendx Technologies signs consulting agreement | ||
| LAMPETIA | 0,050 | 0,00 % | EQS-News: LEHNER INVESTMENTS AG: Jahresabschluss 2024 mit positivem Ergebnis | EQS-News: LEHNER INVESTMENTS AG
/ Schlagwort(e): Jahresergebnis
LEHNER INVESTMENTS AG: Jahresabschluss 2024 mit positivem Ergebnis
30.06.2025 / 16:18 CET/CEST
Für den... ► Artikel lesen | |
| VEECO INSTRUMENTS | 18,000 | +1,69 % | University of Michigan synthesizes high-quality 2D molybdenum disulfide using Veeco's Fiji ALD system | ||
| OBDUCAT | 0,047 | -2,08 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025 | Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen | |
| ACACIA RESEARCH | 3,160 | +2,60 % | ACACIA RESEARCH CORP - 8-K, Current Report | ||
| ADVANCE ZINCTEK | 0,488 | +3,83 % | ADVANCE ZINCTEK LIMITED: Update on Tariffs Announced by Trump Administration Today | ||
| NANOFOCUS | 1,116 | +1,31 % | NanoFocus: Hauptaktionär plant Squeeze-out | Die Carl Mahr Holding GmbH hat ein offizielles Verlangen auf Durchführung eines aktienrechtlichen Squeeze-outs bei der NanoFocus AG übermittelt. Demnach soll die Hauptversammlung einen Beschluss fassen... ► Artikel lesen | |
| NANOVIRICIDES | 1,390 | +0,72 % | WHO Extended Global Emergency Status of MPox Epidemic - Development of Treatment for MPox with NV-387 is Timely, Says NanoViricides | SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development... ► Artikel lesen |
RIBER SA gehört der Branche Nanotechnologie an. Die relative Kursveränderung beträgt aktuell -1,78 % bei einem Aktienkurs von 3,310 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RIBER SA finden Sie auf Wallstreet Online.